Rodent models of streptozotocin‐induced diabetic nephropathy (Methods in Renal Research)
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2007/05/07
-
Journal
-
Indian UGC (journal)
-
Refrences23
-
Citations337
-
GREG H TESCH
-
TERRI J ALLEN
Abstract
Cite
TESCH, GREG H, and TERRI J ALLEN. “Rodent Models of streptozotocin‐induced Diabetic Nephropathy (Methods in Renal Research)”. Nephrology, vol. 12, no. 3, 2007, pp. 261-6, https://doi.org/10.1111/j.1440-1797.2007.00796.x.
TESCH, G. H., & ALLEN, T. J. (2007). Rodent models of streptozotocin‐induced diabetic nephropathy (Methods in Renal Research). Nephrology, 12(3), 261-266. https://doi.org/10.1111/j.1440-1797.2007.00796.x
TESCH, GREG H, and TERRI J ALLEN. “Rodent Models of streptozotocin‐induced Diabetic Nephropathy (Methods in Renal Research)”. Nephrology 12, no. 3 (2007): 261-66. https://doi.org/10.1111/j.1440-1797.2007.00796.x.
TESCH GH, ALLEN TJ. Rodent models of streptozotocin‐induced diabetic nephropathy (Methods in Renal Research). Nephrology. 2007;12(3):261-6.
Journal Categories
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the genitourinary system
Urology
Medicine
Medicine (General)
You May Also Like
- Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: a systematic review and meta-analysis based on observational cohort studies
- Chronic kidney disease of uncertain aetiology: prevalence and causative factors in a developing country
- What do we know about chronic kidney disease in India: first report of the Indian CKD registry
- Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?
- Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Can murine diabetic nephropathy be separated from superimposed acute renal failure? | Kidney International |
| 63 | 2005 |
| Calcium channel blockers, either amlodipine or mibefradil, ameliorate renal injury in experimental diabetes | Kidney International |
| 19 | 2004 |
| The diabetogenic antibiotic streptozotocin modifies the tryptic digest pattern for peptides of the enzyme O-GlcNAc-selective N-acetyl-β-d-glucosaminidase that contain amino acid residues essential for enzymatic activity | Biochemical Pharmacology |
| 9 | 2006 |
| Extent and Persistence of Streptozotocin-Induced DNA Damage and Cell Proliferation in Rat Kidney as Determined by in Vivo Alkaline Elution and BrdUrd Labeling Assays | Toxicology and Applied Pharmacology |
| 53 | 1995 |
Impact of genetic background on nephropathy in diabetic mice | American Journal of Physiology-Renal Physiology |
| 193 | 2006 |
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Inhibition of Interleukin-33 to Reduce Glomerular Endothelial Inflammation in Diabetic Kidney Disease | Kidney International Reports |
| 2024 | |
| Dapagliflozin attenuates renal fibrosis by suppressing angiotensin II/TGFβ signaling in diabetic mice | Journal of Diabetes and its Complications |
| 2024 | |
| Lipid nanoparticles of quercetin (QU-Lip) alleviated pancreatic microenvironment in diabetic male rats: The interplay between oxidative stress – unfolded protein response (UPR) – autophagy, and their regulatory miRNA | Life Sciences |
| 2024 | |
| Methanolic Extract of Merremia emarginata (Burm. f.) Hallier f. Attenuates Renal Damage in Streptozotocin-Induced Diabetic Nephropathy in Rats. | Obesity Medicine | 2024 | ||
Effects of conditioned media derived from human Wharton’s jelly mesenchymal stem cells on diabetic nephropathy and hepatopathy via modulating TGF-β and apelin signaling pathways in male rats | BMC Endocrine Disorders |
| 2024 |
Citations Analysis
The category
Medicine: Medicine (General) 127
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Thrombospondin-1 Is an Endogenous Activator of TGF-β in Experimental Diabetic Nephropathy In Vivo and was published in 2007. The most recent citation comes from a 2024 study titled Methanolic Extract of Merremia emarginata (Burm. f.) Hallier f. Attenuates Renal Damage in Streptozotocin-Induced Diabetic Nephropathy in Rats.. This article reached its peak citation in 2023, with 32 citations. It has been cited in 215 different journals, 26% of which are open access. Among related journals, the Journal of Diabetes Research cited this research the most, with 12 citations. The chart below illustrates the annual citation trends for this article.